Public transit mobility as a leading indicator of COVID-19 transmission in 40 cities during the first wave of the pandemic

The rapid global emergence of the COVID-19 pandemic in early 2020 created urgent demand for leading indicators to track the spread of the virus and assess the consequences of public health measures designed to limit transmission. Public transit mobility, which has been shown to be responsive to prev...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PeerJ (San Francisco, CA) Ročník 12; s. e17455
Hlavní autoři: Soucy, Jean-Paul R., Sturrock, Shelby L., Berry, Isha, Westwood, Duncan J., Daneman, Nick, Fisman, David, MacFadden, Derek R., Brown, Kevin A.
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States PeerJ. Ltd 31.05.2024
PeerJ Inc
Témata:
ISSN:2167-8359, 2167-8359
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract The rapid global emergence of the COVID-19 pandemic in early 2020 created urgent demand for leading indicators to track the spread of the virus and assess the consequences of public health measures designed to limit transmission. Public transit mobility, which has been shown to be responsive to previous societal disruptions such as disease outbreaks and terrorist attacks, emerged as an early candidate. We conducted a longitudinal ecological study of the association between public transit mobility reductions and COVID-19 transmission using publicly available data from a public transit app in 40 global cities from March 16 to April 12, 2020. Multilevel linear regression models were used to estimate the association between COVID-19 transmission and the value of the mobility index 2 weeks prior using two different outcome measures: weekly case ratio and effective reproduction number. Over the course of March 2020, median public transit mobility, measured by the volume of trips planned in the app, dropped from 100% (first quartile (Q )-third quartile (Q ) = 94-108%) of typical usage to 10% (Q -Q = 6-15%). Mobility was strongly associated with COVID-19 transmission 2 weeks later: a 10% decline in mobility was associated with a 12.3% decrease in the weekly case ratio (exp( ) = 0.877; 95% confidence interval (CI): [0.859-0.896]) and a decrease in the effective reproduction number ( = -0.058; 95% CI: [-0.068 to -0.048]). The mobility-only models explained nearly 60% of variance in the data for both outcomes. The adjustment for epidemic timing attenuated the associations between mobility and subsequent COVID-19 transmission but only slightly increased the variance explained by the models. Our analysis demonstrated the value of public transit mobility as a leading indicator of COVID-19 transmission during the first wave of the pandemic in 40 global cities, at a time when few such indicators were available. Factors such as persistently depressed demand for public transit since the onset of the pandemic limit the ongoing utility of a mobility index based on public transit usage. This study illustrates an innovative use of "big data" from industry to inform the response to a global pandemic, providing support for future collaborations aimed at important public health challenges.
AbstractList Background The rapid global emergence of the COVID-19 pandemic in early 2020 created urgent demand for leading indicators to track the spread of the virus and assess the consequences of public health measures designed to limit transmission. Public transit mobility, which has been shown to be responsive to previous societal disruptions such as disease outbreaks and terrorist attacks, emerged as an early candidate. Methods We conducted a longitudinal ecological study of the association between public transit mobility reductions and COVID-19 transmission using publicly available data from a public transit app in 40 global cities from March 16 to April 12, 2020. Multilevel linear regression models were used to estimate the association between COVID-19 transmission and the value of the mobility index 2 weeks prior using two different outcome measures: weekly case ratio and effective reproduction number. Results Over the course of March 2020, median public transit mobility, measured by the volume of trips planned in the app, dropped from 100% (first quartile (Q1)–third quartile (Q3) = 94–108%) of typical usage to 10% (Q1–Q3 = 6–15%). Mobility was strongly associated with COVID-19 transmission 2 weeks later: a 10% decline in mobility was associated with a 12.3% decrease in the weekly case ratio (exp(β) = 0.877; 95% confidence interval (CI): [0.859–0.896]) and a decrease in the effective reproduction number (β = −0.058; 95% CI: [−0.068 to −0.048]). The mobility-only models explained nearly 60% of variance in the data for both outcomes. The adjustment for epidemic timing attenuated the associations between mobility and subsequent COVID-19 transmission but only slightly increased the variance explained by the models. Discussion Our analysis demonstrated the value of public transit mobility as a leading indicator of COVID-19 transmission during the first wave of the pandemic in 40 global cities, at a time when few such indicators were available. Factors such as persistently depressed demand for public transit since the onset of the pandemic limit the ongoing utility of a mobility index based on public transit usage. This study illustrates an innovative use of “big data” from industry to inform the response to a global pandemic, providing support for future collaborations aimed at important public health challenges.
Background The rapid global emergence of the COVID-19 pandemic in early 2020 created urgent demand for leading indicators to track the spread of the virus and assess the consequences of public health measures designed to limit transmission. Public transit mobility, which has been shown to be responsive to previous societal disruptions such as disease outbreaks and terrorist attacks, emerged as an early candidate. Methods We conducted a longitudinal ecological study of the association between public transit mobility reductions and COVID-19 transmission using publicly available data from a public transit app in 40 global cities from March 16 to April 12, 2020. Multilevel linear regression models were used to estimate the association between COVID-19 transmission and the value of the mobility index 2 weeks prior using two different outcome measures: weekly case ratio and effective reproduction number. Results Over the course of March 2020, median public transit mobility, measured by the volume of trips planned in the app, dropped from 100% (first quartile (Q.sub.1 )-third quartile (Q.sub.3 ) = 94-108%) of typical usage to 10% (Q.sub.1 -Q.sub.3 = 6-15%). Mobility was strongly associated with COVID-19 transmission 2 weeks later: a 10% decline in mobility was associated with a 12.3% decrease in the weekly case ratio (exp([beta]) = 0.877; 95% confidence interval (CI): [0.859-0.896]) and a decrease in the effective reproduction number ([beta] = -0.058; 95% CI: [-0.068 to -0.048]). The mobility-only models explained nearly 60% of variance in the data for both outcomes. The adjustment for epidemic timing attenuated the associations between mobility and subsequent COVID-19 transmission but only slightly increased the variance explained by the models. Discussion Our analysis demonstrated the value of public transit mobility as a leading indicator of COVID-19 transmission during the first wave of the pandemic in 40 global cities, at a time when few such indicators were available. Factors such as persistently depressed demand for public transit since the onset of the pandemic limit the ongoing utility of a mobility index based on public transit usage. This study illustrates an innovative use of "big data" from industry to inform the response to a global pandemic, providing support for future collaborations aimed at important public health challenges.
The rapid global emergence of the COVID-19 pandemic in early 2020 created urgent demand for leading indicators to track the spread of the virus and assess the consequences of public health measures designed to limit transmission. Public transit mobility, which has been shown to be responsive to previous societal disruptions such as disease outbreaks and terrorist attacks, emerged as an early candidate. We conducted a longitudinal ecological study of the association between public transit mobility reductions and COVID-19 transmission using publicly available data from a public transit app in 40 global cities from March 16 to April 12, 2020. Multilevel linear regression models were used to estimate the association between COVID-19 transmission and the value of the mobility index 2 weeks prior using two different outcome measures: weekly case ratio and effective reproduction number. Over the course of March 2020, median public transit mobility, measured by the volume of trips planned in the app, dropped from 100% (first quartile (Q.sub.1 )-third quartile (Q.sub.3 ) = 94-108%) of typical usage to 10% (Q.sub.1 -Q.sub.3 = 6-15%). Mobility was strongly associated with COVID-19 transmission 2 weeks later: a 10% decline in mobility was associated with a 12.3% decrease in the weekly case ratio (exp([beta]) = 0.877; 95% confidence interval (CI): [0.859-0.896]) and a decrease in the effective reproduction number ([beta] = -0.058; 95% CI: [-0.068 to -0.048]). The mobility-only models explained nearly 60% of variance in the data for both outcomes. The adjustment for epidemic timing attenuated the associations between mobility and subsequent COVID-19 transmission but only slightly increased the variance explained by the models. Our analysis demonstrated the value of public transit mobility as a leading indicator of COVID-19 transmission during the first wave of the pandemic in 40 global cities, at a time when few such indicators were available. Factors such as persistently depressed demand for public transit since the onset of the pandemic limit the ongoing utility of a mobility index based on public transit usage. This study illustrates an innovative use of "big data" from industry to inform the response to a global pandemic, providing support for future collaborations aimed at important public health challenges.
The rapid global emergence of the COVID-19 pandemic in early 2020 created urgent demand for leading indicators to track the spread of the virus and assess the consequences of public health measures designed to limit transmission. Public transit mobility, which has been shown to be responsive to previous societal disruptions such as disease outbreaks and terrorist attacks, emerged as an early candidate. We conducted a longitudinal ecological study of the association between public transit mobility reductions and COVID-19 transmission using publicly available data from a public transit app in 40 global cities from March 16 to April 12, 2020. Multilevel linear regression models were used to estimate the association between COVID-19 transmission and the value of the mobility index 2 weeks prior using two different outcome measures: weekly case ratio and effective reproduction number. Over the course of March 2020, median public transit mobility, measured by the volume of trips planned in the app, dropped from 100% (first quartile (Q )-third quartile (Q ) = 94-108%) of typical usage to 10% (Q -Q = 6-15%). Mobility was strongly associated with COVID-19 transmission 2 weeks later: a 10% decline in mobility was associated with a 12.3% decrease in the weekly case ratio (exp( ) = 0.877; 95% confidence interval (CI): [0.859-0.896]) and a decrease in the effective reproduction number ( = -0.058; 95% CI: [-0.068 to -0.048]). The mobility-only models explained nearly 60% of variance in the data for both outcomes. The adjustment for epidemic timing attenuated the associations between mobility and subsequent COVID-19 transmission but only slightly increased the variance explained by the models. Our analysis demonstrated the value of public transit mobility as a leading indicator of COVID-19 transmission during the first wave of the pandemic in 40 global cities, at a time when few such indicators were available. Factors such as persistently depressed demand for public transit since the onset of the pandemic limit the ongoing utility of a mobility index based on public transit usage. This study illustrates an innovative use of "big data" from industry to inform the response to a global pandemic, providing support for future collaborations aimed at important public health challenges.
The rapid global emergence of the COVID-19 pandemic in early 2020 created urgent demand for leading indicators to track the spread of the virus and assess the consequences of public health measures designed to limit transmission. Public transit mobility, which has been shown to be responsive to previous societal disruptions such as disease outbreaks and terrorist attacks, emerged as an early candidate.BackgroundThe rapid global emergence of the COVID-19 pandemic in early 2020 created urgent demand for leading indicators to track the spread of the virus and assess the consequences of public health measures designed to limit transmission. Public transit mobility, which has been shown to be responsive to previous societal disruptions such as disease outbreaks and terrorist attacks, emerged as an early candidate.We conducted a longitudinal ecological study of the association between public transit mobility reductions and COVID-19 transmission using publicly available data from a public transit app in 40 global cities from March 16 to April 12, 2020. Multilevel linear regression models were used to estimate the association between COVID-19 transmission and the value of the mobility index 2 weeks prior using two different outcome measures: weekly case ratio and effective reproduction number.MethodsWe conducted a longitudinal ecological study of the association between public transit mobility reductions and COVID-19 transmission using publicly available data from a public transit app in 40 global cities from March 16 to April 12, 2020. Multilevel linear regression models were used to estimate the association between COVID-19 transmission and the value of the mobility index 2 weeks prior using two different outcome measures: weekly case ratio and effective reproduction number.Over the course of March 2020, median public transit mobility, measured by the volume of trips planned in the app, dropped from 100% (first quartile (Q1)-third quartile (Q3) = 94-108%) of typical usage to 10% (Q1-Q3 = 6-15%). Mobility was strongly associated with COVID-19 transmission 2 weeks later: a 10% decline in mobility was associated with a 12.3% decrease in the weekly case ratio (exp(β) = 0.877; 95% confidence interval (CI): [0.859-0.896]) and a decrease in the effective reproduction number (β = -0.058; 95% CI: [-0.068 to -0.048]). The mobility-only models explained nearly 60% of variance in the data for both outcomes. The adjustment for epidemic timing attenuated the associations between mobility and subsequent COVID-19 transmission but only slightly increased the variance explained by the models.ResultsOver the course of March 2020, median public transit mobility, measured by the volume of trips planned in the app, dropped from 100% (first quartile (Q1)-third quartile (Q3) = 94-108%) of typical usage to 10% (Q1-Q3 = 6-15%). Mobility was strongly associated with COVID-19 transmission 2 weeks later: a 10% decline in mobility was associated with a 12.3% decrease in the weekly case ratio (exp(β) = 0.877; 95% confidence interval (CI): [0.859-0.896]) and a decrease in the effective reproduction number (β = -0.058; 95% CI: [-0.068 to -0.048]). The mobility-only models explained nearly 60% of variance in the data for both outcomes. The adjustment for epidemic timing attenuated the associations between mobility and subsequent COVID-19 transmission but only slightly increased the variance explained by the models.Our analysis demonstrated the value of public transit mobility as a leading indicator of COVID-19 transmission during the first wave of the pandemic in 40 global cities, at a time when few such indicators were available. Factors such as persistently depressed demand for public transit since the onset of the pandemic limit the ongoing utility of a mobility index based on public transit usage. This study illustrates an innovative use of "big data" from industry to inform the response to a global pandemic, providing support for future collaborations aimed at important public health challenges.DiscussionOur analysis demonstrated the value of public transit mobility as a leading indicator of COVID-19 transmission during the first wave of the pandemic in 40 global cities, at a time when few such indicators were available. Factors such as persistently depressed demand for public transit since the onset of the pandemic limit the ongoing utility of a mobility index based on public transit usage. This study illustrates an innovative use of "big data" from industry to inform the response to a global pandemic, providing support for future collaborations aimed at important public health challenges.
ArticleNumber e17455
Audience Academic
Author Berry, Isha
Westwood, Duncan J.
Daneman, Nick
Sturrock, Shelby L.
MacFadden, Derek R.
Brown, Kevin A.
Soucy, Jean-Paul R.
Fisman, David
Author_xml – sequence: 1
  givenname: Jean-Paul R.
  orcidid: 0000-0002-8422-2326
  surname: Soucy
  fullname: Soucy, Jean-Paul R.
  organization: Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
– sequence: 2
  givenname: Shelby L.
  orcidid: 0000-0003-4795-3258
  surname: Sturrock
  fullname: Sturrock, Shelby L.
  organization: Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
– sequence: 3
  givenname: Isha
  surname: Berry
  fullname: Berry, Isha
  organization: Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
– sequence: 4
  givenname: Duncan J.
  orcidid: 0000-0001-6320-9053
  surname: Westwood
  fullname: Westwood, Duncan J.
  organization: Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
– sequence: 5
  givenname: Nick
  surname: Daneman
  fullname: Daneman, Nick
  organization: Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada, Department of Medicine, University of Toronto, Toronto, Ontario, Canada, ICES, Toronto, Ontario, Canada
– sequence: 6
  givenname: David
  surname: Fisman
  fullname: Fisman, David
  organization: Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
– sequence: 7
  givenname: Derek R.
  surname: MacFadden
  fullname: MacFadden, Derek R.
  organization: Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
– sequence: 8
  givenname: Kevin A.
  orcidid: 0000-0002-1483-2188
  surname: Brown
  fullname: Brown, Kevin A.
  organization: Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada, ICES, Toronto, Ontario, Canada, Public Health Ontario, Toronto, Ontario, Canada
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38832041$$D View this record in MEDLINE/PubMed
BookMark eNptkt1rFDEUxQep2Fr75LsEBBFk13xn5knK-rVQqA_qa8hkkt2UbLImmUr9683strIrnXmYcOecHzf3nufNSYjBNM1LBOdCIPF-a0y6mSNBGXvSnGHExawlrDs5OJ82FznfwPq0mMOWPGtOSdsSDCk6a_58G3vvNChJhewK2MTeeVfugMpAAW_U4MIKuDA4rUpMIFqwuP65_DhD3d6zcTm7GKoEUAi0K85kMIxpspW1AdalXMBvdWsm71TZqjCYjdMvmqdW-Wwu7r_nzY_Pn74vvs6urr8sF5dXM80oL7PeYtExJCyCjPQM40FbOlDYWqQ7hi0m2gpkeiIGzI3iqqdCE8uZNoJwgch5s9xzh6hu5Da5jUp3Miond4WYVlKl4rQ30ggEB6SI5tzSXpGWI6wQ5521VGHKKuvDnrUd-40ZtAl1CP4IevwnuLVcxVuJEKK8zrwS3t4TUvw1mlxknaA23qtg4pglgZwy0dXdVunrvXSlam8u2FiRepLLyxYRSiARU0vzR1T13Q25psW6Wj8yvDkwrI3yZZ2jH0tdYz4Wvjq87L9bPqSnCtBeoFPMORkr6_7VxKktOC8RlFNI5S6kchfS6nn3n-cB-5j6L3H_5p8
CitedBy_id crossref_primary_10_1016_j_cstp_2025_101378
crossref_primary_10_1057_s41599_024_03376_9
Cites_doi 10.1186/s12992-021-00672-w
10.1126/science.abb8021
10.1371/journal.pone.0000758
10.1126/science.abb4218
10.1001/jamanetworkopen.2021.23139
10.1007/s00168-022-01193-z
10.1503/cmaj.210132
10.1038/s41598-021-92892-8
10.1186/s12916-020-01615-9
10.1038/s42949-021-00030-0
10.1002/bimj.202000112
10.36501/0197-9191/21-026
10.32614/RJ-2017-066
10.2139/ssrn.3569909
10.1001/jama.2020.6602
10.3201/eid2606.200357
10.1038/s41467-021-21776-2
10.1016/j.ijregi.2022.06.002
10.1007/s10900-021-00971-8
10.1038/s42254-021-00407-1
10.1186/s12879-021-05950-x
10.1093/aje/kwt133
10.1038/s41467-021-21358-2
10.1016/S1473-3099(20)30120-1
10.1371/journal.pone.0246772
10.1038/s41598-020-77316-3
10.1038/s41562-021-01079-8
10.1038/s41598-021-81442-x
10.1177/0020852321997552
10.1016/j.ijtst.2021.11.003
ContentType Journal Article
Copyright 2024 Soucy et al.
COPYRIGHT 2024 PeerJ. Ltd.
2024 Soucy et al. 2024 Soucy et al.
Copyright_xml – notice: 2024 Soucy et al.
– notice: COPYRIGHT 2024 PeerJ. Ltd.
– notice: 2024 Soucy et al. 2024 Soucy et al.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.7717/peerj.17455
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList



MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
Statistics
EISSN 2167-8359
ExternalDocumentID oai_doaj_org_article_e710d1a3c66f4ba38612a1669ff4a245
PMC11146320
A813430375
38832041
10_7717_peerj_17455
Genre Journal Article
GeographicLocations Canada
United Kingdom
France
Australia
Japan
Germany
GeographicLocations_xml – name: United Kingdom
– name: Canada
– name: Germany
– name: France
– name: Japan
– name: Australia
GroupedDBID 53G
5VS
88I
8FE
8FH
AAFWJ
AAYXX
ABUWG
ADBBV
ADRAZ
AENEX
AFFHD
AFKRA
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
CITATION
DIK
DWQXO
ECGQY
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HYE
IAO
IEA
IHR
IHW
ITC
KQ8
LK8
M2P
M48
M7P
M~E
OK1
PHGZM
PHGZT
PIMPY
PQGLB
PQQKQ
PROAC
RPM
W2D
YAO
CGR
CUY
CVF
ECM
EIF
H13
NPM
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c546t-bf279517f1053b522dcf4d408f1c952f23cf71eb37d26ea6ab47c3f65ce736713
IEDL.DBID DOA
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001241160000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2167-8359
IngestDate Fri Oct 03 12:53:26 EDT 2025
Tue Nov 04 02:05:36 EST 2025
Thu Oct 02 11:41:40 EDT 2025
Tue Nov 11 10:55:17 EST 2025
Tue Nov 04 18:18:09 EST 2025
Thu May 22 21:24:32 EDT 2025
Mon Jul 21 06:00:17 EDT 2025
Tue Nov 18 22:26:50 EST 2025
Sat Nov 29 05:32:05 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords COVID-19
SARS-CoV-2
Urban mobility
Public transit
Social distancing
Infectious disease surveillance
Physical distancing
Human mobility
Non-pharmaceutical interventions
Language English
License https://creativecommons.org/licenses/by/4.0
2024 Soucy et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c546t-bf279517f1053b522dcf4d408f1c952f23cf71eb37d26ea6ab47c3f65ce736713
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4795-3258
0000-0002-8422-2326
0000-0001-6320-9053
0000-0002-1483-2188
OpenAccessLink https://doaj.org/article/e710d1a3c66f4ba38612a1669ff4a245
PMID 38832041
PQID 3064579717
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_e710d1a3c66f4ba38612a1669ff4a245
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11146320
proquest_miscellaneous_3064579717
gale_infotracmisc_A813430375
gale_infotracacademiconefile_A813430375
gale_healthsolutions_A813430375
pubmed_primary_38832041
crossref_citationtrail_10_7717_peerj_17455
crossref_primary_10_7717_peerj_17455
PublicationCentury 2000
PublicationDate 2024-05-31
PublicationDateYYYYMMDD 2024-05-31
PublicationDate_xml – month: 05
  year: 2024
  text: 2024-05-31
  day: 31
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Diego, USA
PublicationTitle PeerJ (San Francisco, CA)
PublicationTitleAlternate PeerJ
PublicationYear 2024
Publisher PeerJ. Ltd
PeerJ Inc
Publisher_xml – name: PeerJ. Ltd
– name: PeerJ Inc
References Citymapper (10.7717/peerj.17455/ref-11) 2020a
Noh (10.7717/peerj.17455/ref-28) 2021; 16
Miyama (10.7717/peerj.17455/ref-27) 2022; 4
Günther (10.7717/peerj.17455/ref-20) 2021; 63
Zhang (10.7717/peerj.17455/ref-38) 2021; 46
Askitas (10.7717/peerj.17455/ref-3) 2021; 11
Brunori (10.7717/peerj.17455/ref-7) 2020
Dong (10.7717/peerj.17455/ref-17) 2020; 20
Du (10.7717/peerj.17455/ref-18) 2020; 26
Jae Moon (10.7717/peerj.17455/ref-23) 2021; 87
Alessandretti (10.7717/peerj.17455/ref-2) 2022; 4
Asseo (10.7717/peerj.17455/ref-4) 2020; 10
Kraemer (10.7717/peerj.17455/ref-24) 2020; 368
Leung (10.7717/peerj.17455/ref-25) 2021; 12
Hale (10.7717/peerj.17455/ref-21) 2021; 5
Fraser (10.7717/peerj.17455/ref-19) 2007; 2
Brown (10.7717/peerj.17455/ref-6) 2021; 193
Alene (10.7717/peerj.17455/ref-1) 2021; 21
Buckee (10.7717/peerj.17455/ref-8) 2020; 368
Ilin (10.7717/peerj.17455/ref-22) 2021; 11
Carozzi (10.7717/peerj.17455/ref-9) 2022; 72
Rocha (10.7717/peerj.17455/ref-33) 2020
Soucy (10.7717/peerj.17455/ref-34) 2021; 4
Tariq (10.7717/peerj.17455/ref-36) 2020; 18
Park (10.7717/peerj.17455/ref-30) 2020; 323
Zukowski (10.7717/peerj.17455/ref-39) 2023
Nouvellet (10.7717/peerj.17455/ref-29) 2021; 12
YouGov (10.7717/peerj.17455/ref-37) 2022
Citymapper (10.7717/peerj.17455/ref-14) 2021
Liu (10.7717/peerj.17455/ref-26) 2021
Stier (10.7717/peerj.17455/ref-35) 2021; 1
Cori (10.7717/peerj.17455/ref-15) 2019
R Core Team (10.7717/peerj.17455/ref-32) 2021
Qi (10.7717/peerj.17455/ref-31) 2023; 12
Chen (10.7717/peerj.17455/ref-10) 2021; 17
Brooks (10.7717/peerj.17455/ref-5) 2017; 9
Citymapper (10.7717/peerj.17455/ref-13) 2020c
Citymapper (10.7717/peerj.17455/ref-12) 2020b
Cori (10.7717/peerj.17455/ref-16) 2013; 178
References_xml – volume: 17
  start-page: 22
  issue: 1
  year: 2021
  ident: 10.7717/peerj.17455/ref-10
  article-title: A cross-country core strategy comparison in China, Japan, Singapore and South Korea during the early COVID-19 pandemic
  publication-title: Globalization and Health
  doi: 10.1186/s12992-021-00672-w
– volume: 368
  start-page: 145
  issue: 6487
  year: 2020
  ident: 10.7717/peerj.17455/ref-8
  article-title: Aggregated mobility data could help fight COVID-19
  publication-title: Science
  doi: 10.1126/science.abb8021
– volume: 2
  start-page: e758
  issue: 8
  year: 2007
  ident: 10.7717/peerj.17455/ref-19
  article-title: Estimating individual and household reproduction numbers in an emerging epidemic
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0000758
– volume: 368
  start-page: 493
  issue: 6490
  year: 2020
  ident: 10.7717/peerj.17455/ref-24
  article-title: The effect of human mobility and control measures on the COVID-19 epidemic in China
  publication-title: Science
  doi: 10.1126/science.abb4218
– volume: 4
  start-page: e2123139
  issue: 8
  year: 2021
  ident: 10.7717/peerj.17455/ref-34
  article-title: Trends in interregional travel to shopping malls and restaurants before and after differential COVID-19 restrictions in the greater Toronto area
  publication-title: JAMA Network Open
  doi: 10.1001/jamanetworkopen.2021.23139
– volume: 72
  start-page: 163
  issue: 1
  year: 2022
  ident: 10.7717/peerj.17455/ref-9
  article-title: Urban density and COVID-19: understanding the US experience
  publication-title: The Annals of Regional Science
  doi: 10.1007/s00168-022-01193-z
– volume: 193
  start-page: E592
  issue: 17
  year: 2021
  ident: 10.7717/peerj.17455/ref-6
  article-title: The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
  publication-title: Canadian Medical Association Journal
  doi: 10.1503/cmaj.210132
– year: 2021
  ident: 10.7717/peerj.17455/ref-32
  publication-title: R: a language and environment for statistical computing
– year: 2021
  ident: 10.7717/peerj.17455/ref-14
  article-title: Citymapper mobility index comes to an end
– volume: 11
  start-page: 13531
  year: 2021
  ident: 10.7717/peerj.17455/ref-22
  article-title: Public mobility data enables COVID-19 forecasting and management at local and global scales
  publication-title: Scientific Reports
  doi: 10.1038/s41598-021-92892-8
– volume: 18
  start-page: 166
  issue: 1
  year: 2020
  ident: 10.7717/peerj.17455/ref-36
  article-title: Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020
  publication-title: BMC Medicine
  doi: 10.1186/s12916-020-01615-9
– year: 2023
  ident: 10.7717/peerj.17455/ref-39
  article-title: To close budget gaps, transit agencies face hard decisions in 2023
– volume: 1
  start-page: 31
  year: 2021
  ident: 10.7717/peerj.17455/ref-35
  article-title: Early pandemic COVID-19 case growth rates increase with city size
  publication-title: npj Urban Sustainability
  doi: 10.1038/s42949-021-00030-0
– volume: 63
  start-page: 490
  issue: 3
  year: 2021
  ident: 10.7717/peerj.17455/ref-20
  article-title: Nowcasting the COVID-19 pandemic in Bavaria
  publication-title: Biometrical Journal
  doi: 10.1002/bimj.202000112
– year: 2021
  ident: 10.7717/peerj.17455/ref-26
  publication-title: Literature review and data analysis on the impacts of prolonged events on transit system ridership
  doi: 10.36501/0197-9191/21-026
– year: 2022
  ident: 10.7717/peerj.17455/ref-37
  article-title: Personal measures taken to avoid COVID-19
– volume: 9
  start-page: 378
  issue: 2
  year: 2017
  ident: 10.7717/peerj.17455/ref-5
  article-title: glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling
  publication-title: The R Journal
  doi: 10.32614/RJ-2017-066
– year: 2020
  ident: 10.7717/peerj.17455/ref-7
  article-title: Searching for the peak google trends and the Covid-19 outbreak in Italy
  doi: 10.2139/ssrn.3569909
– volume: 323
  start-page: 2129
  issue: 21
  year: 2020
  ident: 10.7717/peerj.17455/ref-30
  article-title: Information technology-based tracing strategy in response to COVID-19 in South Korea—privacy controversies
  publication-title: The Journal of the American Medical Association
  doi: 10.1001/jama.2020.6602
– year: 2020a
  ident: 10.7717/peerj.17455/ref-11
  article-title: Citymapper mobility index: about the data
– volume: 26
  start-page: 1341
  issue: 6
  year: 2020
  ident: 10.7717/peerj.17455/ref-18
  article-title: Serial interval of COVID-19 among publicly reported confirmed cases
  publication-title: Emerging Infectious Diseases
  doi: 10.3201/eid2606.200357
– volume: 12
  start-page: 1501
  year: 2021
  ident: 10.7717/peerj.17455/ref-25
  article-title: Real-time tracking and prediction of COVID-19 infection using digital proxies of population mobility and mixing
  publication-title: Nature Communications
  doi: 10.1038/s41467-021-21776-2
– volume: 4
  start-page: 53
  year: 2022
  ident: 10.7717/peerj.17455/ref-27
  article-title: Factors associated with time lag between symptom onset and reporting in the first epidemic wave of COVID-19 in Osaka, Japan
  publication-title: IJID Regions
  doi: 10.1016/j.ijregi.2022.06.002
– volume: 46
  start-page: 903
  issue: 5
  year: 2021
  ident: 10.7717/peerj.17455/ref-38
  article-title: Public health messages about face masks early in the COVID-19 pandemic: perceptions of and impacts on Canadians
  publication-title: Journal of Community Health
  doi: 10.1007/s10900-021-00971-8
– volume: 4
  start-page: 12
  year: 2022
  ident: 10.7717/peerj.17455/ref-2
  article-title: What human mobility data tell us about COVID-19 spread
  publication-title: Nature Reviews Physics
  doi: 10.1038/s42254-021-00407-1
– volume: 21
  start-page: 257
  issue: 1
  year: 2021
  ident: 10.7717/peerj.17455/ref-1
  article-title: Serial interval and incubation period of COVID-19: a systematic review and meta-analysis
  publication-title: BMC Infectious Diseases
  doi: 10.1186/s12879-021-05950-x
– year: 2020b
  ident: 10.7717/peerj.17455/ref-12
  article-title: Citymapper on twitter: “In our latest release available today we are starting to share some stats about mobility in cities in the hope we can be helpful https://t.co/Kq1j7koeU0”
– year: 2019
  ident: 10.7717/peerj.17455/ref-15
  article-title: EpiEstim: estimate time varying reproduction numbers from epidemic curves
– volume: 178
  start-page: 1505
  issue: 9
  year: 2013
  ident: 10.7717/peerj.17455/ref-16
  article-title: A new framework and software to estimate time-varying reproduction numbers during epidemics
  publication-title: American Journal of Epidemiology
  doi: 10.1093/aje/kwt133
– volume: 12
  start-page: 1090
  issue: 1
  year: 2021
  ident: 10.7717/peerj.17455/ref-29
  article-title: Reduction in mobility and COVID-19 transmission
  publication-title: Nature Communications
  doi: 10.1038/s41467-021-21358-2
– volume: 20
  start-page: 533
  issue: 5
  year: 2020
  ident: 10.7717/peerj.17455/ref-17
  article-title: An interactive web-based dashboard to track COVID-19 in real time
  publication-title: The Lancet Infectious Diseases
  doi: 10.1016/S1473-3099(20)30120-1
– volume: 16
  start-page: e0246772
  issue: 2
  year: 2021
  ident: 10.7717/peerj.17455/ref-28
  article-title: Estimation of the fraction of COVID-19 infected people in U.S. states and countries worldwide
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0246772
– volume: 10
  start-page: 20527
  year: 2020
  ident: 10.7717/peerj.17455/ref-4
  article-title: Tracking COVID-19 using taste and smell loss google searches is not a reliable strategy
  publication-title: Scientific Reports
  doi: 10.1038/s41598-020-77316-3
– volume: 5
  start-page: 529
  issue: 4
  year: 2021
  ident: 10.7717/peerj.17455/ref-21
  article-title: A global panel database of pandemic policies (Oxford COVID-19 government response tracker)
  publication-title: Nature Human Behaviour
  doi: 10.1038/s41562-021-01079-8
– year: 2020
  ident: 10.7717/peerj.17455/ref-33
  article-title: The flurry of daily pandemic data can be overwhelming. Here’s how to make sense of it
– volume: 11
  start-page: 1972
  year: 2021
  ident: 10.7717/peerj.17455/ref-3
  article-title: Estimating worldwide effects of non-pharmaceutical interventions on COVID-19 incidence and population mobility patterns using a multiple-event study
  publication-title: Scientific Reports
  doi: 10.1038/s41598-021-81442-x
– year: 2020c
  ident: 10.7717/peerj.17455/ref-13
  article-title: Citymapper mobility index
– volume: 87
  start-page: 651
  issue: 3
  year: 2021
  ident: 10.7717/peerj.17455/ref-23
  article-title: A comparative study of COVID-19 responses in South Korea and Japan: political nexus triad and policy responses
  publication-title: International Review of Administrative Sciences
  doi: 10.1177/0020852321997552
– volume: 12
  start-page: 34
  issue: 1
  year: 2023
  ident: 10.7717/peerj.17455/ref-31
  article-title: Impacts of COVID-19 on public transit ridership
  publication-title: International Journal of Transportation Science and Technology
  doi: 10.1016/j.ijtst.2021.11.003
SSID ssj0000826083
Score 2.3322074
Snippet The rapid global emergence of the COVID-19 pandemic in early 2020 created urgent demand for leading indicators to track the spread of the virus and assess the...
Background The rapid global emergence of the COVID-19 pandemic in early 2020 created urgent demand for leading indicators to track the spread of the virus and...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e17455
SubjectTerms Analysis
Australia
Big data
Canada
Circuit components
Cities - epidemiology
COVID-19
COVID-19 - epidemiology
COVID-19 - transmission
Economic indicators
Epidemics
Epidemiology
France
Germany
Human mobility
Humans
Infectious disease surveillance
Infectious Diseases
Japan
Longitudinal Studies
Pandemics
Physical distancing
Public Health
Public transit
SARS-CoV-2
Social aspects
Statistics
Terrorism
Transportation
United Kingdom
Title Public transit mobility as a leading indicator of COVID-19 transmission in 40 cities during the first wave of the pandemic
URI https://www.ncbi.nlm.nih.gov/pubmed/38832041
https://www.proquest.com/docview/3064579717
https://pubmed.ncbi.nlm.nih.gov/PMC11146320
https://doaj.org/article/e710d1a3c66f4ba38612a1669ff4a245
Volume 12
WOSCitedRecordID wos001241160000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2167-8359
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000826083
  issn: 2167-8359
  databaseCode: DOA
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2167-8359
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000826083
  issn: 2167-8359
  databaseCode: M~E
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2167-8359
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000826083
  issn: 2167-8359
  databaseCode: M7P
  dateStart: 20130212
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2167-8359
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000826083
  issn: 2167-8359
  databaseCode: BENPR
  dateStart: 20130212
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content Database
  customDbUrl:
  eissn: 2167-8359
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000826083
  issn: 2167-8359
  databaseCode: PIMPY
  dateStart: 20130212
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 2167-8359
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000826083
  issn: 2167-8359
  databaseCode: M2P
  dateStart: 20130212
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA_aivgifru1nhEKgrD0Nsluso9tbbEPdx6icj4tSTbBhXbvuLu26F_vTLI9dlHwxZc8bCawyUwyv0nmg5ADUHIgNnWW5rmpU1EbkaraqVTzwuAzGDe5CcUm5HSq5vNy1iv1hT5hMT1wXLhDByqwzjS3ReGF0VyBStZZUZTeC81EyF4KqKdnTIUzGFAzgIsYkCfBZDlcOrcK7jsY1NdTQSFT_5_ncU8hDZ0le9rn7BF52MFGehR_9zG549on5P6kexh_Sn7F6ze6QdXTbOjlIji9_qR6TTW9iJ7yFN-nLVrZdOHpyadv5x_SrIxjgN14bwYkVIypDXlWaYxhpIARqW8AJtIbfe1wLH5Z4vXzZWOfka9np19OPqZdWYXU5qLYpMYzCbhKeoBWwArGautFLcbKZ7bMmWfcepmBkS1rVjhdaCOk5b7IrZO8AKP2OdlpF617SSjzAKdcXqtSKeHM2HAD5A6sda5zyfKEvL9d6cp2Ocex9MVFBbYHsqUKbKkCWxJysCVexlQbfyc7RpZtSTA_dvgAUlN1UlP9S2oS8gYZXsVg0-0ur45UxgXHusAJeRcocJ_DL1vdhSvAxDFj1oByf0AJDLOD7re3QlVhFzq1tW5xta7Q-MtlCfNLyIsoZNtZcQVH7VhkCVED8RtMe9jTNj9CevAMA81h8N7_WKhX5AEDGBf9JfbJzmZ15V6Te_Z606xXI3JXztWI7B6fTmefR2ELQjthM2wltLuz88ns-2_C3zgg
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Public+transit+mobility+as+a+leading+indicator+of+COVID-19+transmission+in+40+cities+during+the+first+wave+of+the+pandemic&rft.jtitle=PeerJ+%28San+Francisco%2C+CA%29&rft.au=Soucy%2C+Jean-Paul+R.&rft.au=Sturrock%2C+Shelby+L.&rft.au=Berry%2C+Isha&rft.au=Westwood%2C+Duncan+J.&rft.date=2024-05-31&rft.issn=2167-8359&rft.eissn=2167-8359&rft.volume=12&rft.spage=e17455&rft_id=info:doi/10.7717%2Fpeerj.17455&rft.externalDBID=n%2Fa&rft.externalDocID=10_7717_peerj_17455
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2167-8359&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2167-8359&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2167-8359&client=summon